[Technological and productive trajectory of the human vaccine industry in Mexico: post-Covid-19 perspectives].

Vaccines have transformed health globally. The disruption caused by the Covid-19 pan-demic revealed the fragility of healthcare systems around the world. Those countries with capacities in the development and manufacture of vaccines promoted the increase in financing for the development of possible vaccines. In the case of Mexico, once the world leader in vaccine production, it exhibited decades of neglect and little response capacity to meet the needs brought about by the pandemic. This paper analyzes the evolution of the capacities of the vaccine production industry in Mexico. The methodology makes a critical review of the literature regarding the evolution of the productive and technological trajectory of the vaccine industry. The findings point to the fact that the vaccine industry in Mexico, derived from the deterioration of investment in the sector, the lack of organizational flexibility of the public company that produces vaccines, and the absence of public policies, caused the loss of the capacity to generate autonomy in the vaccine manufacturing, it is therefore imperative to review the need to have local capacities for vaccine manufacturing as a strategic area of development for the nation.